论文标题
疫苗接种,预期寿命和信任:世界各地共同疫苗接种率的模式
Vaccination, life expectancy, and trust: Patterns of COVID-19 vaccination rates around the world
论文作者
论文摘要
我们估计了146个国家 /地区的146个国家和2022年2月在146个国家 /地区的人,社会和经济资本的一组疫苗接种率之间的协方差模式。全球CoVID-19疫苗接种率的可变性的70%可以通过全球范围内的差异来解释。对医生和护士的信任增加了超出HDI超出HDI的预测价值,从而阐明了人类发育水平相似的国家和疫苗可用性水平的疫苗接种率之间有争议的差异。心血管疾病死亡是一般卫生系统有效性的指标,婴儿的免疫覆盖范围是国家水平免疫效力的指标,尽管较弱,但较弱的Covid-19疫苗接种成功的预测指标。经济不平等,感知的腐败,贫困和对卫生系统的投入的指标与COVID-19疫苗接种有很强的双变量相关性,但在控制HDI时不再具有统计学意义。我们的分析确定了维持生命并通过此过程复制的社会结构的轮廓。事实证明,Covid-19-19疫苗是马太福音的一部分,即累积优势和加剧对全球社会和社区的大流行造成的劣势。同时,在危机时期,疫苗接种成功的剩余变异性无法固定在集体和个人代理方面的相当大的范围。公民,医疗专业人士,科学家,记者和政客的疫苗接种运动中的动员和协调至少造成了这种可变性,这是克服疫苗的犹豫和不平等现象。
We estimate patterns of covariation between COVID-19 vaccination rates and a set of widely used indicators of human, social, and economic capital across 146 countries in July 2021 and February 2022. About 70% of the variability in COVID-19 vaccination rates worldwide can be explained by differences in the Human Development Index (HDI) and, specifically, in life expectancy at birth, one year after the campaign debut. Trust in doctors and nurses adds predictive value beyond the HDI, clarifying controversial discrepancies between vaccination rates in countries with similar levels of human development and vaccine availability. Cardiovascular disease deaths, an indicator of general health system effectiveness, and infant measles immunization coverage, an indicator of country-level immunization effectiveness, are also significant, though weaker, predictors of COVID-19 vaccination success. The metrics of economic inequality, perceived corruption, poverty, and inputs into the health system have strong bivariate correlations with COVID-19 vaccination but no longer remain statistically significant when controlling for the HDI. Our analysis identified the contours of a social structure that sustains life and is reproduced through this process. COVID-19 vaccines have proven to be part of the Matthew effect of accumulating advantages and aggravating disadvantages that the pandemic inflicted on societies and communities across the world. At the same time, the remaining variability in vaccination success that cannot be pinned down through these sets of metrics points to a considerable scope for collective and individual agency in a time of crisis. The mobilization and coordination in the vaccination campaigns of citizens, medical professionals, scientists, journalists, and politicians, among others, account for at least some of this variability in overcoming vaccine hesitancy and inequity.